Auriga Laboratories, Inc. Expects Q1 2007 Gross Revenue to Exceed a Record $8 Million

LOS ANGELES--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company with products for the treatment of xerostomia, dermatological conditions, and acute respiratory diseases, estimates gross revenues will exceed a record $8 million for the three months ended March 31, 2007, as compared to $6.2 million in gross revenue it had anticipated. The company also expects to report positive cash flow.